# BMED holdings: all 56 positions

> All 56 BMED holdings with weights, as of Oct 13, 2026. The top 3 are MRNA 5.55%, GILD 5.50% and DHR 5.32%. Download the full list as a CSV.

Data as of Oct 13, 2026. Rebuilt every trading night.

BMED held 56 positions as of Oct 13, 2026. Moderna is the largest at 5.55%; the top 10 are 43.5% of the fund.

Source: iShares (BlackRock) (https://www.ishares.com/us/products/316007/x/latest-holdings.csv).

| # | Holding | Ticker | Weight |
| --- | --- | --- | --- |
| 1 | Moderna | MRNA | 5.55% |
| 2 | Gilead Sciences | GILD | 5.50% |
| 3 | Danaher | DHR | 5.32% |
| 4 | Abbvie | ABBV | 4.93% |
| 5 | Thermo Fisher Scientific Inc | TMO | 4.42% |
| 6 | Iqvia Holdings Inc | IQV | 3.70% |
| 7 | Waters Corp | WAT | 3.65% |
| 8 | Biogen | BIIB | 3.64% |
| 9 | Mettler Toledo | MTD | 3.59% |
| 10 | Vertex Pharmaceuticals | VRTX | 3.17% |
| 11 | Merck & Co Inc | MRK | 3.09% |
| 12 | Edwards Lifesciences | EW | 2.98% |
| 13 | Roche Ps Par AG | ROP | 2.72% |
| 14 | Amgen Inc | AMGN | 2.45% |
| 15 | Dexcom Inc | DXCM | 2.44% |
| 16 | Illumina Inc | ILMN | 2.24% |
| 17 | Johnson & Johnson | JNJ | 2.11% |
| 18 | Halozyme Therapeutics | HALO | 2.05% |
| 19 | Genmab Sponsored ADR | GMAB | 1.95% |
| 20 | Novartis AG | NOVN | 1.86% |
| 21 | Argenx SE ADR | ARGX | 1.64% |
| 22 | Pfizer | PFE | 1.54% |
| 23 | Charles River Laboratories Interna | CRL | 1.52% |
| 24 | Wuxi Biologics Cayman |  | 1.40% |
| 25 | Guardant Health | GH | 1.40% |
| | BLK Csh Fnd Treasury Sl Agency | | 5.47% |
| | USD Cash | | 0.91% |
| | GBP Cash | | 0.00% |
| | HKD Cash | | 0.00% |
| | KRW Cash | | 0.00% |
| | Cash and other net assets | | 0.01% |

The largest 25 of 56 positions are shown. All of them: https://etfiq.com/funds/bmed/holdings/bmed-holdings.csv (CSV) or https://etfiq.com/data/books/bmed.json (JSON).

Fund page: https://etfiq.com/funds/bmed

Cite: ETFIQ, Holdings of BMED, data as of Oct 13, 2026. https://etfiq.com/funds/bmed/holdings/